Common Stock and Stockholders' Equity - Shares Available for Issuance (Details) - shares |
Jul. 31, 2024 |
Jan. 31, 2024 |
|---|---|---|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Number of shares available for grant (in shares) | 19,919,771 | 17,178,454 |
| Total common stock reserved at period end (in shares) | 38,740,615 | |
| Stock options, RSUs and PSUs | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Outstanding stock options and unvested RSUs outstanding (in shares) | 14,835,965 | |
| Number of shares available for grant (in shares) | 19,919,771 | |
| ESPP | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Number of shares available for grant (in shares) | 3,984,879 |
| X | ||||||||||
- Definition Share-based Compensation Arrangement By Share-based Payment Award, Outstanding No definition available.
|
| X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|